Replies to post #285 on Bluebird Bio Inc (BLUE)

[stocksrising]

Good guess , but history shows this company burns cash, and ~$103mm could help if approved…they will still come to market for raise, but hopefully at higher levels, especially if Sickle Cell approved..

FYI:
FDA panel greenlights approval of first human drug using CRISPR

Food and Drug Administration (FDA) advisers cleared the way for the first FDA approval of a human drug using CRISPR technology.

The news: FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee said exa-cel, the sickle cell gene therapy developed by BIO members Vertex Pharmaceuticals and CRISPR Therapeutics, is safe for clinical use.